You are viewing the site in preview mode
Skip to main content
|
Study
|
Country/Ethnicity
|
SNPs evaluated
|
No. of patients
|
Mean age ± SD
|
Protocol
|
Study design
|
Genotyping
|
HWE
|
Outcomes*
|
NOS scores
|
|---|
|
Lledó, 2019 [18]
|
Spain/Caucasian
|
AMH/ AMHR2
|
124
|
23.9 ± 3.5
|
GnRH-A
|
prospective
|
PCR
|
Yes
|
1.2.3
|
6
|
|
Wu, 2019 [21]
|
China/Asian
|
AMH/AMHR2
|
635
|
NA
|
GnRHa
|
prospective
|
PCR
|
Yes
|
1.2.3.4.7
|
6
|
|
Lazaros, 2016 [17]
|
Greece/Caucasian
|
AMHR2
|
300
|
28–38
|
GnRHa
|
prospective
|
PCR
|
Yes
|
3. 4.
|
7
|
|
Cerra, 2016 [15]
|
UK/multiple
|
AMH/AMHR2
|
603
|
NA
|
GnRHa/GnRH-A
|
prospective
|
TaqMan
|
No metion
|
2. 3. 5. 8
|
6
|
|
Peluso, 2015 [19]
|
Brazil
|
AMH/AMHR2
|
186
|
32.5 ± 3.5
|
GnRH-A
|
prospective
|
TaqMan
|
Yes
|
3. 6. 7. 8.
|
6
|
|
Wang, 2015 [20]
|
China/Asian
|
AMH
|
122
|
NA
|
GnRHa
|
retrospective
|
PCR
|
Yes
|
3
|
7
|
|
Karagiorga, 2015 [16]
|
Greece
|
AMH/AMHR2
|
151
|
36 ± 5
|
GnRHa/GnRH-A
|
prospective
|
PCR
|
Yes
|
1. 2. 3. 4.
|
7
|
- *Outcomes: 1. stimulation duration; 2. Gn dosage; 3. No. of oocytes retrieved; 4. clinical pregnancy rate; 5. live birth; 6. AMH level; 7. No. of MII oocytes; 8. No. of embryo. HWE Hardy-Weinberg equilibrium
